Novel mutation in an Egyptian patient with infantile Canavan disease
- 223 Downloads
Canavan disease (CD) is a rare fatal childhood neurological autosomal recessive genetic disease caused by mutations in the ASPA gene, which lead to catalytic deficiency of the ASPA enzyme that catalyzes the deacetylation of NAA. It is a severe progressive leukodystrophy characterized by spongiform degeneration of the white matter of the brain. CD occurs frequently among Ashkenazi Jewish population, however it has been reported in many other ethnic groups with significantly lower frequency. Here, we report on a 2 year-old Egyptian child with severe CD who harbors a novel homozygous missense variant (c.91G > T, p.V31F) in the ASPA gene. The clinical, radiological, and molecular genetic profiles are reviewed in details.
KeywordsCanavan disease Aspartoacylase N-acetyl-aspartate MRI MRS
Hatem Zayed is supported by the Qatar University grant QUUG-CAS-DHS-14/15-3.
Compliance with ethical standards
Conflict of interest
All author declare that they have no conflict of interest.
- Bitto E, Bingman CA, Wesenberg GE, McCoy JG, Phillips Jr GN (2007) Structure of aspartoacylase, the brain enzyme impaired in canavan disease. Proc Natl Acad Sci U S A 104:456–461. doi: 10.1073/pnas.0607817104
- Valk J, Van der Knaap M (2005) Magnetic resonance of myelin, myelination and myelin disorders. Science 246:815–818Google Scholar